Anika Therapeutics Inc (ANIK)

SG&A Expense Growth

-38.39%

Quarterly · Period ending:

ANIK logo

ANIK SG&A Expense Growth

Latest reported-38.39%
ANIK Quarterly SG&A Growth (QoQ) (0.00% → -38.39%)
High-resolution chart · PNG

ANIK sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
27.9445%
30.0018%
2.1658%
11.9351%
-2.2264%
42.7803%
0%
-12.5%
0%
33.3333%
-33.3333%
28.5714%
40%
-37.5%
100%
0%
0%
-20%
0%
25%
33.3333%
0%
50%
0%
0%
0%
0%
0%
0%
-60%
-72.2222%
1,700%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.